http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008511317-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-15001 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21026 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P21-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4717 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
| filingDate | 2005-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2008-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2008511317-A |
| titleOfInvention | ACE-inhibited whey hydrolyzate |
| abstract | The present invention relates to a compound having an antihypertensive action. More particularly, the present invention relates to the release of ACE (Angiotensin 1-converting enzyme) inhibitory peptides from whey proteins. The present invention relates to a method for enzymatically producing a protein hydrolyzate having angiotensin converting enzyme (ACE) inhibitory activity, comprising a broad-spectrum endoprotease and a beta-lactoglobulin (BLG) -containing substrate in a first reaction step And subsequent treatment with a proline specific endoprotease in a second reaction step. The invention also relates to an ACE-inhibiting hydrolyzate obtainable according to such a method and methods of using the hydrolyzate. [Selection figure] None |
| priorityDate | 2004-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 287.